Fundraising FoxSpayVac
Madison, US · 3 known investors
Find your way into SpayVac
Sign up to see every warm intro you have to SpayVac
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SpayVac team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SpayVac develops a single-dose vaccine platform for fertility management in production animals, including applications for boar taint prevention in swine, population control in bison, and sterility in farmed fish. The company targets livestock producers seeking to reduce handling stress and labor while maintaining animal welfare and productivity.
Founders & leadership
TD
Thomas D'OrazioExecutiveHe has over 20 years of experience in strategic operations, product management, and business development, including prior work leading a publicly-traded entity.
MF
Mark FrakerVP – OperationsMark Fraker brings experience in wildlife ecology and immunocontraception, with prior roles as a contractor, petroleum industry environmental scientist, and government manager, as well as university-level teaching in marine mammal ecology. He now leads operations at SpayVac, which develops single-dose fertility management vaccines for livestock.
UB
Ursula BechertVP – Research & DevelopmentUrsula Bechert has held academic leadership positions spanning over 25 years, with expertise in veterinary medicine including small animal, exotic, and wildlife practice, as well as extensive experience developing educational programs in zoo medicine and wildlife rehabilitation.
T
TomCEO
Board
JR
Jeffrey RusinowBoard director
JP
Jeff PetersonChairman
Investors · 3
Reported raises · per SEC filings
Form D private placements$426.2K disclosed across 1 round · 2025
▶$426.2KraisedMay 2025 · 9 investors · Other Health CareRule 506(b)
▶$426.2KraisedMay 2025 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas D'OrazioExecutive Officer, Director
- Jeffrey RusinowDirector
- Mark FrakerExecutive Officer
- Jeff PetersonDirector
- Ursula BechertExecutive Officer
- Offering amount
- $1M
- Amount sold
- $426.2K
- First sale
- May 2025
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does SpayVac do?
- SpayVac develops a single-dose vaccine platform for fertility management in production animals, including applications for boar taint prevention in swine, population control in bison, and sterility in farmed fish. The company targets livestock producers seeking to reduce handling stress and labor while maintaining animal welfare and productivity.
- Who are SpayVac's investors?
- SpayVac's investors include Central Texas Angel Network, Symbiotic Ventures, Serra Ventures.
- How much funding has SpayVac raised?
- SpayVac has disclosed $426.2K raised across 1 round.
- Where is SpayVac headquartered?
- SpayVac is headquartered in Madison, US.